Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-23-015258
Filing Date
2023-04-27
Accepted
2023-04-27 16:06:12
Documents
16
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A grph-20221231.htm   iXBRL 10-K/A 1067797
2 EX-31.1 grph-ex31_1.htm EX-31 21171
3 EX-31.2 grph-ex31_2.htm EX-31 21159
  Complete submission text file 0000950170-23-015258.txt   3634022

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grph-20221231.xsd EX-101.SCH 86405
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grph-20221231_pre.xml EX-101.PRE 519463
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grph-20221231_def.xml EX-101.DEF 337041
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grph-20221231_cal.xml EX-101.CAL 57315
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grph-20221231_lab.xml EX-101.LAB 683758
10 EXTRACTED XBRL INSTANCE DOCUMENT grph-20221231_htm.xml XML 10342
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40532 | Film No.: 23856813
SIC: 2836 Biological Products, (No Diagnostic Substances)